The current valuation score of TherapeuticsMD Inc is 7.83, ranking 119 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 125.32, which is 17.44% below the recent high of 147.17 and 135.70% above the recent low of -44.73.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.